Related Experiment Video
Updated: May 10, 2026

Surgical Management of Meatal Stenosis with Meatoplasty
Published on: November 30, 2010
Pediatric Hidradenitis Suppurativa: An Overview
Jordanna Roesler1, Allison Gregory1,2, Wingfield Rehmus1,3,2
1Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
Insights
Pediatric hidradenitis suppurativa (HS) is a chronic skin condition often underdiagnosed in children. Early recognition and management are crucial for improving quality of life and addressing associated health issues.
Area of Science:
- Dermatology
- Pediatrics
- Inflammatory Diseases
Background:
- Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition impacting patient quality of life.
- Pediatric HS is often underrecognized, potentially leading to underestimated incidence rates.
- Diagnosis and management of HS in children present unique clinical challenges.
Purpose of the Study:
- To discuss the epidemiology of pediatric hidradenitis suppurativa.
- To review the pathogenesis of HS in the pediatric population.
- To outline current comorbidities and management strategies for pediatric HS.
Main Methods:
- Literature review on pediatric hidradenitis suppurativa.
- Analysis of epidemiological data for pediatric HS.
- Synthesis of information on pathogenesis, comorbidities, and treatment.
Main Results:
- Pediatric HS is associated with significant psychosocial impact.
- Comorbidities include depression, anxiety, inflammatory bowel disease, metabolic syndrome, and obesity.
- Limited literature exists on the efficacy and long-term outcomes of HS treatments in children.
Conclusions:
- Early diagnosis and management of pediatric HS are essential.
- Addressing comorbidities is critical in the comprehensive care of affected children.
- Further research is needed to establish effective long-term treatment protocols for pediatric HS.
Abstract:
Hidradenitis suppurativa (HS) is a chronic, recurring inflammatory skin disease that significantly impacts the quality of life of patients.[1] HS is more common in adults and adolescents, although true incidence rates may be underestimated due to a lack of earlier recognition of HS in children.[2] Pediatric HS is a challenging clinical entity to diagnose and manage. Although considered uncommon, treatment of pediatric HS can drastically improve psychosocial well-being and should be considered in children presenting with recurring painful skin nodules, abscesses, scarring and sinus tracts. Multiple comorbidities are associated with pediatric HS, including depression, anxiety, inflammatory bowel disease, metabolic syndrome, and obesity.[3] Medical management of pediatric HS poses a unique challenge given the paucity of literature surrounding efficacy and long-term treatment outcomes in pediatric patients. The purpose of this article is to discuss the epidemiology, pathogenesis, comorbidities, and management of pediatric HS.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Acute Pyelonephritis I: Introduction
Staphylococcal Skin Infections
Acne Infection

